CN109078112A - 调理肿瘤、炎症类疾病配方及其制备方法 - Google Patents
调理肿瘤、炎症类疾病配方及其制备方法 Download PDFInfo
- Publication number
- CN109078112A CN109078112A CN201811173914.2A CN201811173914A CN109078112A CN 109078112 A CN109078112 A CN 109078112A CN 201811173914 A CN201811173914 A CN 201811173914A CN 109078112 A CN109078112 A CN 109078112A
- Authority
- CN
- China
- Prior art keywords
- parts
- tumour
- formula
- conditioning
- class disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 41
- 201000010099 disease Diseases 0.000 title claims abstract description 38
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 38
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 30
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000009472 formulation Methods 0.000 title abstract description 6
- 230000003750 conditioning effect Effects 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 24
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 18
- 241000723418 Carya Species 0.000 claims abstract description 17
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 16
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 16
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 16
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 16
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 15
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 15
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 15
- 241001506047 Tremella Species 0.000 claims abstract description 15
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 14
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 238000000746 purification Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 241000222684 Grifola Species 0.000 claims description 13
- 241000245665 Taraxacum Species 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 4
- 102000004317 Lyases Human genes 0.000 claims description 4
- 108090000856 Lyases Proteins 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 244000088415 Raphanus sativus Species 0.000 claims 4
- 241001251949 Xanthium sibiricum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 241000220259 Raphanus Species 0.000 description 7
- 150000004676 glycans Chemical class 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical group CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 102100038567 Properdin Human genes 0.000 description 1
- 108010005642 Properdin Proteins 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000005809 anti-tumor immunity Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005839 oxidative dehydrogenation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种调理肿瘤、炎症类疾病配方及其制备方法,包括如下重量份配方:香菇15‑30份、银耳15‑30份、山药10‑25份、枸杞15‑25份、姬松茸12‑28份、羊肚菌15‑30份、猴头菇15‑30份、茯苓5‑12份、黄精8‑15份、蒲公英3‑12份、鱼腥草8‑15份。本发明所述的调理肿瘤、炎症类疾病配方及其制备方法制备工艺简单,原料价格便宜,采用纯食品级中药提纯物,对身体无副作用。
Description
技术领域
本发明属于中药组合物,具体涉及一种调理肿瘤、炎症类疾病配方及其制备方法。
背景技术
目前的治疗手段中,一种药物只能治疗单一疾病。在肿瘤治疗过程中,西医治疗肿瘤多是以化疗和放疗为主,对人体具有很强的副作用。真菌内还有大量多糖和抗癌物,可增强人体免疫力,因此为降低化疗和放疗对人体的损伤、降低患者治疗痛苦,越来越多学者将真菌应用于临床治疗中,起到辅助抑制肿瘤和保护肿瘤病人的化疗、放疗造成的损伤作用。目前被应用于中药抗肿瘤的真菌类多为人参、紫芝等名贵中药材,但由于菌类中药配方提取物含量较低,导致成品价格昂贵,不利于大范围推广。
哮喘是一种慢性炎症导致的一种疾病,肠胃炎、胃溃疡等通常因微生物感染,总体来讲,上述疾病是由于病毒或微生物感染造成;从中医分析类风湿、强直性脊柱炎等软组织疾病的主要原因是由人体软组织营养不良引起的,由于人体软组织缺乏合理的营养。真菌内含有的大量多糖、抑癌物质可在为人体提供营养的同时增强人体免疫力。因此亟待提供一种以真菌为治疗基料的中药配方在调理肿瘤的过程中为人体提供营养物质以调理由于营养不良造成的疾病。
发明内容
为解决上述问题,本发明设计了一种调理肿瘤、炎症类疾病配方及其制备方法,制备工艺简单,原料价格便宜,采用纯食品级中药提纯物,对身体无副作用。
为实现上述目的,本发明采用了以下技术方案:调理肿瘤、炎症类疾病配方,包括如下重量份配方:香菇15-30份、银耳15-30份、山药10-25份、枸杞15-25份、姬松茸12-28份、羊肚菌15-30份、猴头菇15-30份、茯苓5-12份、黄精8-15份、蒲公英3-12份、鱼腥草8-15份。
作为本发明调理肿瘤、炎症类疾病配方的进一步改进:还包括如下重量份配方,8-10份莱菔子、10-25份黑芝麻。
作为本发明调理肿瘤、炎症类疾病配方的进一步改进:还包括5-12重量份的灰树花。
作为本发明调理肿瘤、炎症类疾病配方的进一步改进:包括如下重量份配方香菇15份、银耳15份、山药10份、枸杞15份、姬松茸15份、羊肚菌18份、猴头菇18份、茯苓6份、黄精8份、蒲公英5份、鱼腥草8份、莱菔子8份、黑芝麻10份、灰树花5份。
作为本发明调理肿瘤、炎症类疾病配方的进一步改进:包括如下重量份配方香菇20份、银耳20份、山药15份、枸杞15份、姬松茸20份、羊肚菌20份、猴头菇20份、茯苓10份、黄精10份、蒲公英10份、鱼腥草10份、莱菔子8份、黑芝麻20份、灰树花10份。
作为本发明调理肿瘤、炎症类疾病配方的进一步改进:包括如下重量份配方香菇30份、银耳30份、山药25份、枸杞25份、姬松茸25份、羊肚菌30份、猴头菇30份、茯苓12份、黄精15份、蒲公英12份、鱼腥草15份、莱菔子10份、黑芝麻25份、灰树花12份。
为实现上述目的,本发明采用了以下技术方案:一种调理肿瘤、炎症类疾病配方的制备方法,包括以下步骤:
1)破壁粉碎:按重量份取已干燥处理的上述中药配方,粉碎至150-200目;
2)提取:先向混合粉末中加入20倍于混合粉末体积的纯净水浸泡1-3小时,然后对混合液进行煎煮0.5-1小时,至剩余水量为加入水量的1/3,水煮液冷却沉淀后进行过滤处理,得滤液;
3)对步骤2)进行重复操作3次,混合3次滤液;
4)粗提:将步骤3)中滤液进行醇提、浓缩,即得粗制中药粉;
5)精提:将步骤4)中中药粉进行加入纯净水溶解,将溶解液加入溶解酶酶解,然后离心、醇提并浓缩即得精制中药粉。
作为本发明调理肿瘤、炎症类疾病配方制备方法的进一步改进:所述溶解酶为蛋白酶、纤维素酶和果胶酶。
作为本发明调理肿瘤、炎症类疾病配方制备方法的进一步改进:所述溶解酶用量为粗制中药粉重量的0.5%,常温下以25KHz条件下超声处理1.5小时
有益效果
与现有技术相比,本发明具有以下技术效果:本发明的调理肿瘤、炎症类疾病配方及其制备方法,为纯营养物质制成,治疗效果好,对人体无副作用。且营养成分高,可为人体提供大量营养以治疗由于人体营养不良造成的疾病。一药多治,在调理、抑制肿瘤的效果下可对哮喘、肠胃炎、胃溃疡等疾病进行治疗、调理,其丰富的营养物质和中药物质对由于人体营养不良造成的类风湿、强直性脊柱炎具有很好的疗效。
本配方中的香菇、姬松茸、羊肚菌、灰树花等菌类含有大量硒物质和抑癌、抗肿瘤成分,其中姬松茸的抗肿瘤成分主要有核酸、外源凝集素、甾醇和脂肪酸和多糖,以提高人体免疫力。
羊肚菌中含有丰富硒物质硒是人体红细胞谷胱甘肽过氧化酶的组成成分,可运输大量氧分子来抑制恶性肿瘤,使癌细胞失活;另方面能加强维生素E的抗氧化作用。硒的抗氧化作用能改变致癌物 的代方向,并通过结合而解毒,从而减少或消除致癌的危险。同时羊肚菌内含有丰富的有机锗,具有很强的氧化脱氢能力。与人体血红蛋白结合,保证细胞的有氧代谢,以对人体癌肿、骨质疏松等具有调理、保健作用。
灰树花中D-fration可有效激活人体免疫细胞,如NK细胞,抗毒T细胞,吞噬细胞等,从而可以达到抑制肿瘤细胞生长,诱导癌细胞凋亡的功效,可有效对人体肿瘤、增生组织、癌变组织进行调理治疗,在姬松茸或羊肚菌等对人体进行调理时,灰树花的加入更进一步提供了配方的调理功效。
山药内富含多糖,可刺激和调节人类免疫系统,山药多糖对环磷酰胺所导致的细胞免疫抑制有对抗作用,能使被抑制的细胞免疫功能部分或全部恢复正常,同时山药还能加强白细胞的吞噬作用以对癌变细胞、器官具有很好的治疗效果。
香菇中含有大量多糖、酶、氨基酸和维生素,香菇多糖能提高辅助性T淋巴细胞的活力而增强人体体液免疫功能,同时提高巨噬细胞的吞噬功能和T淋巴细胞的杀伤活性;香菇中含有双链结构的核糖核酸,进入人体后,会产生具有抗癌作用的干扰素,以抑制癌细胞的扩散,起到很好的调理、抑制功能。
银耳含有丰富的蛋白质、脂肪、钙、铁和多种氨基酸、海藻糖、多缩戊糖、 甘露糖醇等肝糖,银耳中富含维生素D能防止钙的流失,可有效预防骨质疏松,富含硒等微量元素,增强机体抗肿瘤的免疫力。
枸杞养肝,滋肾,润肺,枸杞中富含枸杞多糖,提高免疫调节和抗肿瘤作用。
猴头菇富含蛋白质、维生素和无机盐,可提高淋巴细胞转化率,提升白细胞等作用,因而可提高人体免疫力,猴头菇低脂肪、高蛋白的特性可提供人体所需的大量营养成分。
黄精壮筋骨,益精髓、对肺结核具有很好治疗效果。
蒲公英富含维生素A、维生素C,同时蒲公英含有大量蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,可为人体提供营养物质。
鱼腥草可增强WBC对白色葡萄球菌的吞噬能力,提高血清备解素以对慢性气管炎等疾病具有很好的治疗效果。
具体实施方式
下面结合具体实施例对发明作进一步说明,本实施例以本发明技术方案为前提,给出了详细的实施方式。
实施例1
一种调理肿瘤、炎症类疾病配方,包括如下重量份配方香菇15份、银耳15份、山药10份、枸杞15份、姬松茸15份、羊肚菌18份、猴头菇18份、茯苓6份、黄精8份、蒲公英5份、鱼腥草8份。
实施例2
一种调理肿瘤、炎症类疾病配方,其特征在于,包括如下重量份配方香菇15份、银耳15份、山药10份、枸杞15份、姬松茸15份、羊肚菌18份、猴头菇18份、茯苓6份、黄精8份、蒲公英5份、鱼腥草8份、莱菔子8份、黑芝麻10份、灰树花5份。
实施例3
一种调理肿瘤、炎症类疾病配方,包括如下重量份配方香菇20份、银耳20份、山药15份、枸杞15份、姬松茸20份、羊肚菌20份、猴头菇20份、茯苓10份、黄精10份、蒲公英10份、鱼腥草10份、莱菔子8份、黑芝麻20份、灰树花10份。
实施例4
一种调理肿瘤、炎症类疾病配方,包括如下重量份配方香菇30份、银耳30份、山药25份、枸杞25份、姬松茸25份、羊肚菌30份、猴头菇30份、茯苓12份、黄精15份、蒲公英12份、鱼腥草15份、莱菔子10份、黑芝麻25份、灰树花12份。
本发明中所述的实施例1-4中调理肿瘤、炎症类疾病配方的制备方法包括以下步骤:
1)破壁粉碎:按重量份取已干燥处理的上述中药配方,粉碎至150目;
2)提取:先向混合粉末中加入20倍于混合粉末体积的纯净水浸泡1小时,然后对混合液进行煎煮0.5小时,至剩余水量为加入水量的1/3,水煮液冷却沉淀后进行过滤处理,得滤液;
3)对步骤2)进行重复操作3次,混合3次滤液;
4)粗提:将步骤3)中滤液进行醇提、浓缩,即得粗制中药粉;
5)精提:将步骤4)中中药粉进行加入纯净水溶解,将溶解液加入蛋白酶、纤维素酶和果胶酶组成的溶解酶酶解,然后离心、醇提并浓缩即得精制中药粉。
其中蛋白酶、纤维素酶和果胶酶总质量为粗制中药粉重量的0.5%,在酶解破壁过程中,在常温下以25KHz条件下超声处理1.5小时。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专业的技术人员,在不脱离本发明技术方案范围内,当可利用上述揭示的技术内容作出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。
Claims (9)
1.调理肿瘤、炎症类疾病配方,其特征在于,包括如下重量份配方:香菇15-30份、银耳15-30份、山药10-25份、枸杞15-25份、姬松茸12-28份、羊肚菌15-30份、猴头菇15-30份、茯苓5-12份、黄精8-15份、蒲公英3-12份、鱼腥草8-15份。
2.如权利要求1所述的调理肿瘤、炎症类疾病配方,其特征在于:还包括如下重量份配方,8-10份莱菔子、10-25份黑芝麻。
3.如权利要求2所述的调理肿瘤、炎症类疾病配方,其特征在于:还包括5-12重量份的灰树花。
4.如权利要求3所述的调理肿瘤、炎症类疾病配方,其特征在于,包括如下重量份配方香菇15份、银耳15份、山药10份、枸杞15份、姬松茸15份、羊肚菌18份、猴头菇18份、茯苓6份、黄精8份、蒲公英5份、鱼腥草8份、莱菔子8份、黑芝麻10份、灰树花5份。
5.如权利要求3所述的调理肿瘤、炎症类疾病配方,其特征在于,包括如下重量份配方香菇20份、银耳20份、山药15份、枸杞15份、姬松茸20份、羊肚菌20份、猴头菇20份、茯苓10份、黄精10份、蒲公英10份、鱼腥草10份、莱菔子8份、黑芝麻20份、灰树花10份。
6.如权利要求3所述的调理肿瘤、炎症类疾病配方,其特征在于,包括如下重量份配方香菇30份、银耳30份、山药25份、枸杞25份、姬松茸25份、羊肚菌30份、猴头菇30份、茯苓12份、黄精15份、蒲公英12份、鱼腥草15份、莱菔子10份、黑芝麻25份、灰树花12份。
7.一种调理肿瘤、炎症类疾病配方的制备方法,其特征在于,包括以下步骤:
1)破壁粉碎:按重量份取已干燥处理的上述中药配方,粉碎至150-200目;
2)提取:先向混合粉末中加入20倍于混合粉末体积的纯净水浸泡1-3小时,然后对混合液进行煎煮0.5-1小时,至剩余水量为加入水量的1/3,水煮液冷却沉淀后进行过滤处理,得滤液;
3)对步骤2)进行重复操作3次,混合3次滤液;
4)粗提:将步骤3)中滤液进行醇提、浓缩,即得粗制中药粉;
5)精提:将步骤4)中中药粉进行加入纯净水溶解,将溶解液加入溶解酶酶解,然后离心、醇提并浓缩即得精制中药粉。
8.如权利要求7所述的调理肿瘤、炎症类疾病配方的制备方法,其特征在于:所述溶解酶为蛋白酶、纤维素酶和果胶酶。
9.如权利要求7所述的调理肿瘤、炎症类疾病配方的制备方法,其特征在于:所述溶解酶用量为粗制中药粉重量的0.5%,常温下以25KHz条件下超声处理1.5小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811173914.2A CN109078112A (zh) | 2018-10-09 | 2018-10-09 | 调理肿瘤、炎症类疾病配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811173914.2A CN109078112A (zh) | 2018-10-09 | 2018-10-09 | 调理肿瘤、炎症类疾病配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109078112A true CN109078112A (zh) | 2018-12-25 |
Family
ID=64843305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811173914.2A Pending CN109078112A (zh) | 2018-10-09 | 2018-10-09 | 调理肿瘤、炎症类疾病配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109078112A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112167614A (zh) * | 2020-10-27 | 2021-01-05 | 袁希福 | 一种用于肿瘤病人和放、化疗病人术后的食疗组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822383A (zh) * | 2010-04-23 | 2010-09-08 | 纪福黛 | 一种适用于肿瘤患者的功能性营养代餐食品及其制备方法 |
CN105687480A (zh) * | 2016-03-03 | 2016-06-22 | 广东福寿仙生物科技有限公司 | 一种免疫调节的中药组合物及制剂 |
CN107375509A (zh) * | 2017-08-04 | 2017-11-24 | 河南省科高植物天然产物开发工程技术有限公司 | 一种用于提高免疫力、预防癌症的保健食品 |
-
2018
- 2018-10-09 CN CN201811173914.2A patent/CN109078112A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822383A (zh) * | 2010-04-23 | 2010-09-08 | 纪福黛 | 一种适用于肿瘤患者的功能性营养代餐食品及其制备方法 |
CN105687480A (zh) * | 2016-03-03 | 2016-06-22 | 广东福寿仙生物科技有限公司 | 一种免疫调节的中药组合物及制剂 |
CN107375509A (zh) * | 2017-08-04 | 2017-11-24 | 河南省科高植物天然产物开发工程技术有限公司 | 一种用于提高免疫力、预防癌症的保健食品 |
Non-Patent Citations (4)
Title |
---|
刘四忠: "河南省知鑫生物科技有限公司", 《美篇HTTPS://WWW.MEIPIAN.CN/1M69QAV6 》 * |
夏丽等: "《临床诊疗思维技巧》", 31 January 2010, 内蒙古科学技术出版社 * |
徐宏喜等: "《抗肿瘤中药现代研究与临床应用》", 30 September 2018, 上海科学技术出版社 * |
程嘉艺: "《药食同源中药材药理研究与应用》", 31 March 2018, 辽宁科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112167614A (zh) * | 2020-10-27 | 2021-01-05 | 袁希福 | 一种用于肿瘤病人和放、化疗病人术后的食疗组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100401925C (zh) | 可有效预防和治疗哮喘的健康饮料的制造方法 | |
CN110720516A (zh) | 骨营养特膳食品及其制备方法和应用 | |
WO2021114586A1 (zh) | 一种具有提高免疫力功能的组合物及其制备方法和应用 | |
CN105031301A (zh) | 一种抗肿瘤中药组合物及其制备方法 | |
CN107412440B (zh) | 一种复方红衣补血口服液及其质量检测方法 | |
CN101664180A (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
CN111771988A (zh) | 适用于糖尿病人食用的营养食品及其制备方法 | |
CN103704351B (zh) | 木瓜牛初乳粉及制备方法 | |
CN105878899A (zh) | 一种对胃黏膜损伤有辅助治疗功能的食药及其制备方法 | |
CN109078112A (zh) | 调理肿瘤、炎症类疾病配方及其制备方法 | |
CN101837045A (zh) | 一种治疗口腔溃疡的美洲大蠊药物组合物及其制备方法 | |
CN104940241B (zh) | 一种防治妇女更年期综合征的硒虫草复方制剂 | |
CN112370516A (zh) | 一种具有活性成分的破壁灵芝孢子粉制品及其制备方法 | |
JP2011184349A (ja) | 頻尿改善組成物、健康食品、及び血流改善組成物 | |
CN109043325A (zh) | 一种食用复合菌粉 | |
JP4368540B2 (ja) | 骨軟化症予防剤 | |
CN108617853A (zh) | 促雏鸡生长、提高蛋鸡产蛋率的饲料添加剂及制备方法 | |
CN108522888A (zh) | 一种促雏鸡生长、提高蛋鸡产蛋率的饲料及其制备方法 | |
CN112450331A (zh) | 一种对虾复合预混合饲料及其制备方法和应用 | |
CN105998373A (zh) | 一种治疗肝炎的保健口服液及其制备方法 | |
CN112043730A (zh) | 一种防治动物疫病的中药生物制剂 | |
KR20170029764A (ko) | 마늘 추출물, 난황 추출물, 유황을 유효성분으로 포함하는 심혈관, 뇌혈관 및 기타 순환기계 질환의 예방, 개선 및 치료 기능성 식품조성물 제공과 그 제조방법과 유기 유황의 물질운반 기능을 유효성분으로 포함하는 건강 기능성 식품조성물 | |
CN113383956B (zh) | 一种黑松露补肾配方及其制备方法 | |
CN109294984A (zh) | 一种体内高效扩增nk细胞的香菇多糖胶囊及其制备方法 | |
CN111729056A (zh) | 抗癌的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181225 |
|
RJ01 | Rejection of invention patent application after publication |